Beat E. Neuenschwander
Novartis (Switzerland) · 72 works · 3,897 citations · h-index 25
Top works
- Critical aspects of the Bayesian approach to phase I cancer trials
- Use of historical control data for assessing treatment effects in clinical trials
- Summarizing historical information on controls in clinical trials
- Robust meta‐analytic‐predictive priors in clinical trials with historical control information
- Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials
- A note on the power prior
- Study of the dog population and the rabies control activities in the Mirigama area of Sri Lanka
- Robust exchangeability designs for early phase clinical trials with multiple strata
- Meta‐analysis of few small studies in orphan diseases
- Bayesian models for subgroup analysis in clinical trials
- Combining MCMC with ‘sequential’ PKPD modelling
- Methodologic challenges of randomized controlled studies on in-home comprehensive geriatric assessment: The EIGER project
- A novel type of somatic embryogenesis in Coffea arabica
- Meta‐analysis of two studies in the presence of heterogeneity with applications in rare diseases
- A proof of concept phase II non‐inferiority criterion
- Predictively consistent prior effective sample sizes
- Trends in the prevalence of infection with mycobacterium tuberculosis in Korea from 1965 to 1995: an analysis of seven surveys by mixture models.
- Bayesian Dose Finding in Oncology for Drug Combinations by Copula Regression
- Determination of the Prevalence of Infection with Mycobacterium tuberculosis among Persons Vaccinated against Bacillus Calmette-Guerin in South Korea
- Simultaneous Diagonalization Algorithms with Applications in Multivariate Statistics